Related Experiment Video

Updated: Aug 19, 2026

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
05:18

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

Heart failure in children -- mechanical assistance

M Deiwick1, A Hoffmeier, T D T Tjan

  • 1Department of Thoracic and Cardiovascular Surgery, University Hospital Münster, Münster, Germany. michael.deiwick@ukmuenster.de

The Thoracic and Cardiovascular Surgeon
|February 11, 2005
PubMed

Insights

Mechanical circulatory support devices are crucial for pediatric heart failure, but options lag behind adult technology. Newer pulsatile devices show promise for children, especially with organ shortages, offering better outcomes than current mainstays.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Mechanical circulatory support (MCS) is vital for pediatric heart failure treatment.
  • Pediatric MCS technology development trails behind adult innovations.
  • Organ donor scarcity exacerbates challenges in pediatric heart transplantation.

Purpose of the Study:

  • To review the current state and advancements in pediatric mechanical circulatory support.
  • To compare the efficacy of emerging pulsatile devices with existing support systems.
  • To highlight the critical considerations for selecting appropriate MCS in pediatric patients.

Main Methods:

  • Review of current literature on pediatric mechanical circulatory support.
  • Analysis of outcomes data for various MCS devices in children.
  • Comparison of pulsatile paracorporeal ventricular assist devices with extracorporeal membrane oxygenation and centrifugal pumps.

Main Results:

  • Newly developed pulsatile paracorporeal ventricular assist devices show excellent results in children.
  • These advanced devices outperform extracorporeal membrane oxygenation and centrifugal pumps for long-term support.
  • Careful consideration of patient physiology, including respiratory failure, is crucial for optimal outcomes, especially in smaller patients.

Conclusions:

  • Pulsatile paracorporeal ventricular assist devices represent a significant advancement in pediatric MCS.
  • These devices offer superior options compared to current mainstays for pediatric heart failure.
  • Tailoring MCS selection to individual pediatric patient needs is paramount for successful treatment.

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...